Broad spectrum ß-lactamase producing Gram-negative bacilli (GNB) in the Gulf Cooperation Council (GCC) states - "The known known and the known unknown" by Zowawi, Hosam M. et al.
Abstract 
Introduction: Various reports from the GCC countries have described the 
isolation of many extended-spectrum ß-lactamase (ESBL), plasmid mediated 
AmpC and carbapenemase producing GNB. Although the states are closely 
located and demographically similar, different enzymes have been described 
from each country. Other widely spread enzymes elsewhere have not ever 
been or rarely described in the region. Here we list the reported broad 
spectrum ß-lactamase enzymes produced by GNB in the GCC states and 
document our justified expectations for future reports. 
Methods: We searched MEDLINE, ICAAC and ICPIC 2011 abstract 
databases for the terms “antibiotics”, “resistance”, and, “Saudi Arabia”, “UAE”, 
“Kuwait”, “Oman”, “Bahrain” or “Qatar”. The word “lactamase” was also 
combined with the countries’ names individually to replace the “antibiotics” and 
“resistance” terms. The results were excluded to cover the literature published 
between 1980 and 2010. We used the reference lists from articles identified 
as further sources. Finally, we studied reports of widely spread ß-lactamase 
enzymes reported elsewhere, to try and identify similar aspects to our regions. 
Our search was restricted to papers in English. 
Results: The CTX-M, SHV and TEM enzymes have been found to be the 
most common ESBL in the GCC. Different variants have been characterized 
from isolates of Saudi Arabia, UAE, Oman, and Kuwait including the rare CTX-
M-55, SHV-28, and the recently described SHV-112 and SHV-122. Other less 
frequently reported ESBL in the GCC states include OXA-1, OXA-9, VEB-1a, 
and VEB-1b. The novel ESBL PME-1 is also believed to be of Gulf origin. The 
only reported plasmid mediated AmpC from the region is the worldwide spread 
DHA-1, which was firstly characterized after the isolation of Salmonella spp 
from Al-Dhahran city. Class D carbapenemases are the most common 
enzyme reported from the GCC. Acinetobacter baumannii collected from the 
GCC states expressed a variety of OXA enzymes including the novel OXA-90, 
-130, -131, and -132, while other isolates expressed OXA-23, -25, -26, -58, 
-66, -72, -78, and -91. Recently, a novel OXA-181 enzyme has been reported 
from  Klebsiella pneumoniae collected from Oman. The widely disseminated 
group A ß-lactamase KPC enzyme has been only described from Saudi Arabia 
and Kuwait in two separate case reports. Although metallo-ß-lactamase 
enzymes are reported worldwide, VIM-types have been characterized from 
limited isolates in Saudi Arabia and Kuwait, while the “panic causing” NDM-1 
has only been reported twice from Oman and Kuwait. Due to the socio-
economic structure of the GCC states, significant migration activity is 
prevalent. Saudi Arabia is also visited annually by more than 1.5 million 
pilgrims. Travel has been found to be a significant contributor in spreading 
antibiotic resistant bacteria, particularly if hospitalization occurs during travel. 
Conclusion: Widely spread ß-lactamase enzymes like KPC, VIM, NDM, and 
OXA-48 are increasingly noticed in the GCC countries. And since novel 
resistance mechanisms have emerged from this region, new enzymes should 
be expected. We suggest keeping track of emerging resistance mechanisms 
by adopting region-wide surveillance. Information provided will help to halt the 
problem by developing further interventional activities including strong 
infection control practices and antimicrobial stewardship programs. 
Results Conclusion 
Many laboratories located in the GCC states as increasingly 
documenting phenotypic observation of broad spectrum                
ß-lactamase resistance among GNB. Widely spread ß-lactamase 
enzymes like KPC, VIM, NDM, and OXA-48 are increasingly 
noticed in the GCC countries, and with out active control will 
become more evident and might increase in prevalence. Since 
novel resistance mechanisms have emerged from this region, new 
enzymes should be expected. We suggest keeping track of 
emerging / introduced resistance mechanisms by adopting region-
wide surveillance. Information provided will help to halt the 
problem by developing further interventional precautions including 
strong infection control practices and implementation of  
antimicrobial stewardship programs. 
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Background 
The emergence and increase in antibiotic resistant organisms is 
a serious concern for modern healthcare practice. In GNB an 
important cause of multi-drug resistance is the production of 
broad spectrum beta-lactamases. In the early 1980s, extended-
spectrum ß-lactamases (ESBLs) that hydrolyze penicillins and 
third-generation cephalosporins emerged 1. In more recent years, 
beta-lactamases that hydrolyze carbapenems have become 
prominent 2.  
Different reports around the world have described the isolation of 
ESBL and carbapenemase producing bacteria. Here we reviews 
types of broad spectrum ß-lactamase producing GNB in the 
Middle East, with a primary focus on states of the Gulf 
Cooperation Council (GCC). Based on the challenges and 
potential risk factors, we will predict future reports of beta-
lactamase enzymes producing by GNB in the GCC states.  
Figure 2. The geographical distribution of broad spectrum β-lactamases in the GCC states.  
 
 
“The known known” 
ESBLs   
•  SHV, TEM, and CTX-M are the most common ESBLs.  
•  CTX-M-15 is the predominant  ESBL in different GCC states 3-10.  
•  Less common CTX-M-ESBLs present in the region 4, 11.  
• VEB-1a and VEB-1b emerged in Kuwait from Pseudomonas aeruginosa 
isolated from two different hospitals 12.  
•  Proteus mirabilis producing VEB-6 was isolated from Oman 13. 
•  SHV-112 and SHV-122 emerged and identified in Kuwait 5,6. 
• PME-1 was emerged in UAE. It was  identified in Pittsburgh from a patient 
who had admission in Dubai 14. 
Carbapenemases  
• The novel chromosomally encoded OXA-90, 130, 131, 132 in A. baumannii 
have emerged in Saudi Arabia 15.   
• Plasmid carried blaOXA-23 was found in A. baumannii isolates of UAE and 
Bahrain 16, 17. 
•  OXA-58 was found in A. baumannii isolated from Kuwait and Bahrain 17, 18.  
•  Different K. pneumoniae isolated from Oman carried plasmids encoding: 
Ø blaOXA-1, blaOXA-9 and other ESBL genes with the blaNDM-1 gene 8.  
Ø  The recently emerged OXA-48-like enzyme OXA-181 9.  
• KPC was isolated in Saudi Arabia 19 and blaKPC gene was found in an E. coli 
isolated from Kuwait that also harboured blaVIM and the emergent SHV-122 6.  
• Two reports documented the detection of NDM-1 producing K. Pneumoniae 
from Oman and Kuwait 8, 20.  
•  VIM enzymes produced by Pseudomonas aeruginosa in Saudi Arabia 21, 22. 
Plasmid mediated AmpC  
•  DHA-1 emerged in Saudi Arabia and was named after Al-Dahran city 23.  
•  No further plasmid mediated AmpC have been ever reported from the region.   
Mobile genetic elements  
•  Class 1 integron 13 
•  insertion sequence 7, 10  
•  Conjugative plasmids 4, 8, 9  
•  Transposons 9 
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- PREDICTIONS - 
 
ESBLs   
•  E. coli producing CTX-M-15-ESBL is likely to keep spreading. 
•  SHV-112 and SHV-122 will be seen more in K. pneumoniae and in other 
organisms in the GCC states and will extend gradually from there. 
•  Less common ESBLs (e.g. VEB) will be rarely detected. 
•  P. aeruginosa producing PME-1 will extend rapidly outside of UAE.     
•  Novel ESBL enzymes will keep emerging from this region.   
Carbapenemases  
•  Outbreaks caused by KPC-producing Enterobacteriaceae 24 will be seen more.  
•  Most carbapenem resistant P. aeruginosa are likely to be due to VIM-production. 
•  OXA-48 will be increasingly reported from Enterobacteriaceae 25.  
•  GCC states will have a very high prevalence of NDM-1 producing bacteria.  
Plasmid mediated AmpC  
•  DHA is disseminated in its origin.   
•  CMY will be detected in association with NDM-1 producing bacteria.  
Why ?! 
• The presence of successful clones in the region (e.g. ST131 E. coli 6, 26).   
•  The overuse and misuse of antibiotics. 
•  Suboptimal hand hygiene and environmental cleaning.  
• Frequent travel and residence from where NDM-1 is in high prevalence  
(foreign workforce, pilgrims, and hospital transfer). 
  
Methods 
“Antibiotic AND resistance AND 
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Figure 1. Summary of the methodology used to search for the literature.   
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